Related Experiment Video
Updated: Aug 13, 2026

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment
Published on: August 2, 2024
Risk factors affecting survival in heart transplant patients
L Almenar1, M L Cardo, L Martínez-Dolz
1Department of Cardiology, La Fe University Hospital, Valencia, Spain.
Insights
Cardiovascular risk factors negatively impact heart transplant (HT) patient survival. While multiple risk factors worsen outcomes, they do not represent an absolute contraindication for HT.
Area of Science:
- Cardiology
- Transplantation Medicine
- Clinical Outcomes Research
Background:
- Cardiovascular risk factors are associated with increased morbidity and mortality in heart transplant (HT) recipients.
- The cumulative effect of multiple risk factors may significantly worsen prognosis, raising questions about transplant contraindications.
Purpose of the Study:
- To evaluate if pre-transplant cardiovascular risk factors lead to excess mortality in heart transplant patients.
- To determine if the presence and number of risk factors contraindicate heart transplantation.
Main Methods:
- Analysis of 384 adult heart transplant recipients (1987-2004), excluding heart-lung, retransplants, and pediatric cases.
- Risk factors assessed included obesity, dyslipidemia, hypertension, prior thoracic surgery, diabetes, and history of ischemic heart disease.
- Kaplan-Meier survival curves and log-rank tests were used to compare survival based on the number of risk factors.
Main Results:
- Overall 10-year survival was 54%, decreasing to 47% by 13 years.
- Ten-year survival rates were 69% (0-1 risk factors), 59% (2-3 risk factors), and 37% (>3 risk factors).
- A statistically significant difference in survival was observed based on the number of risk factors (P = .04).
Conclusions:
- The presence of cardiovascular risk factors in heart transplant candidates is associated with reduced survival rates.
- A combination of multiple risk factors significantly worsens post-transplant outcomes.
- These risk factors, while impactful, should not be considered an absolute contraindication for heart transplantation.
Background:
Certain cardiovascular risk factors have been linked to morbidity and mortality in heart transplant (HT) patients. The sum of various risk factors may have a large cumulative negative effect, leading to a substantially worse prognosis and the need to consider whether HT is contraindicated. The objective of this study was to determine whether the risk factors usually available prior to HT result in an excess mortality in our setting that contraindicates transplantation.
Materials And Methods:
Consecutive patients who underwent heart transplantation from November 1987 to January 2004 were included. Heart-lung transplants, retransplants, and pediatric transplants were excluded. Of the 384 patients, 89% were men. Mean age was 52 years (range, 12 to 67). Underlying disease included ischemic heart disease (52%), idiopathic dilated cardiomyopathy (36%), valvular disease (8%), and other (4%). Variables considered risk factors were obesity (BMI >25), dyslipidemia, hypertension, prior thoracic surgery, diabetes, and history of ischemic heart disease. Survival curves by number of risk factors using Kaplan-Meier and log-rank for comparison of curves.
Results:
Overall patient survival at 1, 5, 10, and 13 years was 76%, 68%, 54%, and 47%, respectively. Survival at 10 years, if fewer than two risk factors were present, was 69%; 59% if two or three factors were present; and 37% if more than three associated risk factors were present (P = .04).
Conclusions:
The presence of certain risk factors in patients undergoing HT resulted in lower survival rates. The combination of various risk factors clearly worsened outcomes. However, we do not believe this should be an absolute contraindication for transplantation.
Related Concept Videos
Kidney Transplant I: Introduction
Heart Failure I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant III: Nursing Management
Pathophysiology of Heart Failure
Kidney Transplant II: Surgical Procedure

